Ephedra Sales Ban Gains Congressional Momentum Following Athlete’s Death
This article was originally published in The Tan Sheet
Executive Summary
Reps. John Sweeney (R-N.Y.) and Greg Walden (R-Ore.) announced plans to challenge ephedra's safety and address restrictions on the sale of the controversial ingredient following the death of professional baseball player Steve Bechler
You may also be interested in...
Nutraquest’s Chinery To Sue Orioles For Liability In Bechler Case
Nutraquest President Robert Chinery is seeking to shift any future liability and damages found against him for the death of Baltimore Orioles pitcher Steve Bechler to the Orioles organization
Xenadrine Safety Misrepresentations Alleged In Bechler Suit v. Cytodyne
Cytodyne's failure to adequately warn consumers about potential risks from taking ephedra-containing Xenadrine RFA-1 is the basis for a wrongful-death lawsuit filed by Orioles pitcher Steve Bechler's widow, Kiley Bechler, July 16
Ephedra Safety Taken Up By House Commerce Cmte, Cytodyne Sent Letter
The House Energy & Commerce Committee launched an investigation into the safety of ephedra Feb. 28 by sending letters to FDA Commissioner Mark McClellan, MD/PhD, and Cytodyne Technologies President Robert Chinery